SCHEMBL6064031

SCHEMBL6064031

CC(C)c1cc(C(C)C)c(P)c(C(C)C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 4/20 0.50
GABRB2 P47870 2/20 0.50
FABP4 P15090 3/20 0.48
FABP3 P05413 2/20 0.48
FABP5 Q01469 1/20 0.46
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
ALDH1A1 P00352 1/20 0.33
GABRB1 P18505 3/20 0.32
LMNA P02545 2/20 0.31
HDAC1 Q13547 1/20 0.30
GAA P10253 1/20 0.30
ROCK2 O75116 1/20 0.30
TRPA1 O75762 2/20 0.30
PTGS1 P23219 1/20 0.30
CACNA1C Q13936 1/20 0.30
CHRM1 P11229 1/20 0.30
SLC6A2 P23975 1/20 0.30
ADRA1A P35348 1/20 0.30
HTR2B P41595 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9369688 0.74 FABP4 (0.56) GABRA1GABRB2FABP4FABP3FABP5
SCHEMBL9064395 0.74 GABRA1 (0.52) GABRA1GABRB2FABP4FABP3FABP5
SCHEMBL3079552 0.74 GABRA1 (0.52) GABRA1GABRB2FABP4FABP3FABP5
SCHEMBL15473364 0.74 GABRA1 (0.38) GABRA1GABRB2FABP4FABP3FABP5
SCHEMBL30317598 0.74 ROCK2 (0.39) GABRA1GABRB2FABP4FABP3FABP5
SCHEMBL30678392 0.74 GABRA1 (0.38) GABRA1GABRB2FABP4FABP3FABP5
Hydrochloric Acid SCHEMBL21331878 0.73 ROCK2 (0.38) GABRA1GABRB2FABP4FABP3FABP5
SCHEMBL878114 0.72 GABRA1 (0.50) GABRA1GABRB2FABP4FABP3FABP5
SCHEMBL5790732 0.72 GABRA1 (0.50) GABRA1GABRB2FABP4FABP3FABP5
SCHEMBL20816450 0.72 GABRA1 (0.50) GABRA1GABRB2FABP4FABP3FABP5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110156766-A Preparation method of silver-catalyzed deuterated five-membered aromatic heterocyclic compound 南京工业大学 2019-08-23 CN claimed
US-20240126170-A1 METHOD OF MANUFACTURING A SEMICONDUCTOR DEVICE AND PHOTORESIST COMPOSITION TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2024-04-18 US disclosed
CN-117420728-A Method for manufacturing semiconductor device and photoresist composition 台湾积体电路制造股份有限公司 2024-01-19 CN disclosed
CN-117280489-A Positive electrode mixture, positive electrode, and secondary battery 大金工业株式会社 2023-12-22 CN disclosed
CN-117223123-A Positive electrode mixture, positive electrode, and secondary battery 大金工业株式会社 2023-12-12 CN disclosed
CN-117223122-A Positive electrode mixture, positive electrode, and secondary battery 大金工业株式会社 2023-12-12 CN disclosed
EP-4273127-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE Samsung Electronics Co., Ltd. (KR) 2023-11-08 EP disclosed
EP-4273125-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE Samsung Electronics Co., Ltd. (KR) 2023-11-08 EP disclosed
EP-4274404-A1 ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME Samsung Electronics Co., Ltd. (KR) 2023-11-08 EP disclosed
EP-4273126-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE Samsung Electronics Co., Ltd. (KR) 2023-11-08 EP disclosed
CN-112955432-B Fused aromatic ring derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2022-11-22 CN disclosed
CN-112955432-A Fused aromatic ring derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2021-06-11 CN disclosed
CN-110156766-A Preparation method of silver-catalyzed deuterated five-membered aromatic heterocyclic compound 南京工业大学 2019-08-23 CN disclosed
US-9200021-B2 Phosphine ligands for catalytic reactions ABBVIE INC. (US) 2015-12-01 US disclosed
US-7030200-B2 Catalysts for olefin polymerization E.I. DU PONT DE NEMOURS AND COMPANY (US) 2006-04-18 US disclosed
US-20050245702-A1 Catalysts for olefin polymerization UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2005-11-03 US disclosed
WO-2003076450-A1 CATALYSTS FOR OLEFIN POLYMERIZATION E.I. DU PONT DE NEMOURS AND COMPANY (US) 2003-09-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245702-A1 Catalysts for olefin polymerization PNMT, PPOX, ETFA GABRA1 4105/4885GABRB2 3632/4885FABP4 2840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.